Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buijs, A.
Right arrow Articles by Lokhorst, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buijs, A.
Right arrow Articles by Lokhorst, H.
Related Collections
Right arrow Neoplasia
Right arrow Transplantation
Right arrow Apoptosis
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 November 2001, Vol. 98, No. 9, pp. 2856-2858

BRIEF REPORT

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies

Arjan Buijs, Pino Poddighe, Richard van Wijk, Wouter van Solinge, Eric Borst, Leo Verdonck, Anton Hagenbeek, Peter Pearson, and Henk Lokhorst

From the Division of Medical Genetics and the Departments of Hematology, Immunology, and Clinical Chemistry, University Medical Center Utrecht, The Netherlands.

Hereditary mutations associated with hematologic malignancies are rare. Heterozygous mutations affecting the hematopoietic transcription factor CBFA2 (also AML1/RUNX1) were recently reported to be associated with familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML, MIM 601399). A new 3-generation family with FPD/AML with a novel CBFA2 mutation is described. In this family, AML was diagnosed in a second-generation male. After allogeneic stem cell transplantation from his human leukocyte antigen-identical sister, a donor-derived, genetically identical leukemia developed in the recipient and the donor. Sequencing analysis identified a G-to-T transition within the CBFA2 gene, which involves codon 198, encoding a conserved aspartic acid within the DNA- binding Runt domain. Three of 5 siblings affected with the FPD/AML trait harbored the mutation in a heterozygous form. This experience underscores the necessity of performing mutation analysis of the CBFA2 gene before sibling allogeneic transplantation in families with FPD/AML.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. J. Owen, C. L. Toze, A. Koochin, D. L. Forrest, C. A. Smith, J. M. Stevens, S. C. Jackson, M.-C. Poon, G. D. Sinclair, B. Leber, et al.
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Blood, December 1, 2008; 112(12): 4639 - 4645.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
K. Kirito, K. Sakoe, D. Shinoda, Y. Takiyama, K. Kaushansky, and N. Komatsu
A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies
Haematologica, January 1, 2008; 93(1): 155 - 156.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. G. Heller, A. C. Glembotsky, M. J. Gandhi, C. L. Cummings, C. J. Pirola, R. F. Marta, L. I. Kornblihtt, J. G. Drachman, and F. C. Molinas
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
Blood, June 15, 2005; 105(12): 4664 - 4670.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Christiansen, M. K. Andersen, and J. Pedersen-Bjergaard
Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation
Blood, September 1, 2004; 104(5): 1474 - 1481.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Harada, Y. Harada, H. Niimi, T. Kyo, A. Kimura, and T. Inaba
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia
Blood, March 15, 2004; 103(6): 2316 - 2324.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. G. Drachman
Inherited thrombocytopenia: when a low platelet count does not mean ITP
Blood, January 15, 2004; 103(2): 390 - 398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Li, J. Yan, C. J. Matheny, T. Corpora, J. Bravo, A. J. Warren, J. H. Bushweller, and N. A. Speck
Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding
J. Biol. Chem., August 29, 2003; 278(35): 33088 - 33096.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Harada, Y. Harada, H. Tanaka, A. Kimura, and T. Inaba
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia
Blood, January 15, 2003; 101(2): 673 - 680.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020